13th Annual World Multispecific Summit By Hanson Wade
20
Sep
-
22
Sep
2022
When
Boston
Massachusetts
USA
Where

The Newly Re-Branded 13th World Multispecifics Summit is the Only End-to-End Meeting Committed Solely to Advancing the Development of Bi- & Multi-Specific Therapeutics With more clinical candidates and commercial success than ever within this rapidly developing space, multi-specifics is evidently the fourth wave of drug discovery. With this, there has never been a hotter time to double down and deliver the holy grail of precision oncology as the true power of bispecifics is recognized. The 13th Annual World Multispecific Summit will deliver a greater scope and penetration of innovative technical content than any other meeting. This year’s re-imagined agenda will cover unique target discovery, mechanistic diversity and translational science as well as novel formats, product design and manufacturability challenges faced in the bispecific field. Whatever your role or interest, you will leave the meeting with concrete methods to employ in your strategy and pipeline to convert the promise of bi- and multi-specific therapeutics into a reality for patients. With 2 tracks of unrivaled content, join with your team to catapult this community into the next generation of translational success, clinical progress, advanced mechanistic diversity, reduced toxicity and higher target affinity. Utilize the pre-conference focus day dedicated to Novel Formats and Immune Cell Modulators of multispecifics to further drive your clinical and antibody engineering strategies forward.

Similar Events

You May Like

(0)
03-04 October 2022
Immuno US: In-Person
(0)
03-05 October 2022
Immunotherapeutics | EUSTM-2022
(0)
03-06 October 2022
14th Annual Immunogenicity & Bioassay Summit
(0)
04-05 October 2022
World Drug Safety Congress Americas 2022
(0)
04-05 October 2022
Healthcare Estates
(0)
04-05 October 2022
BIOPHARM AMERICA: Virtual
(0)
04-06 October 2022
Life Sciences Summit: Coding Innovation Into Our DNA
(0)
04-06 October 2022
4th Extracellular Vesicle-Based Therapeutic Development Summit
(0)
04-07 October 2022
7th Annual Health It + Revenue Cycle Conference
(0)
05-06 October 2022
NEXT GENERATION PHARMACEUTICAL CLEANROOMS

Event

Hanson Wade

0/5
(0)

Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Hanson Wade conferences span high growth fields from pioneering life science, to technology-augmented construction, to radical change in HR. We run events globally, across a huge variety of topics.
Our conferences are built where rapid change leads to greater opportunity for those that are most informed.

20 - 22 Sep 2022
In-Person

Speakers and Delegates
Industry Experts and Thought Leaders

Dept. Head Biologics Core Technologies
Senior Scientist II- Enzymology & Biophysics
Vice President, Protein Sciences and Rational Design
Principal Scientific Researcher - Antibody Engineering
Project Leader Innate Immune Cell Engager
Chief Scientific Officer

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Applied BioMath

Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development. Our Model-Aided Dru

Beacon Targeted Therapies

Make faster and better informed drug development decisions In partnership with the world’s leading drug development experts to help you keep up with the pace of preclinical and clinical research developments. Beacon's customizable, modular, cloud-bas

AlivaMab Discovery Services

AlivaMab Discovery Services is a leader in the discovery of antibody therapeutics, trusted by top-tier pharmaceutical and biotechnology companies to deliver panels of drug-quality human antibodies. We meet our partners' design goals, from simple to e

Carterra

Carterra is a leading provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra’s high throughput LSA™ instrument for monoclonal antibody (mAb) screening and characterization combines patented

GemPharmatech

GemPharmatech Co. Ltd., founded in 2017, is an international biotechnology enterprise specializing in the development of humanized animal models. The management and operation team has nearly 20 years of experience in gene-editing technology and anima

Asimov

Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.

BSP Pharmaceuticals S.p.A.

BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006. In

Ligand Pharmaceuticals

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Our business model creates value for stockholders by providing a diversified portfolio of biotech

Organizer

Get emails from us

 
Thank you
Oops! Something went wrong